ARTICLE | Clinical News
once-monthly Actonel/Benet risedronate regulatory update
January 7, 2013 8:00 AM UTC
On Dec. 25, 2012, Ajinomoto Pharmaceuticals Co. Ltd. (Tokyo, Japan) and Takeda said Japan's Ministry of Health, Labor and Welfare (MHLW) approved once-monthly Actonel/Benet risedronate to treat osteop...